Zuranolone for post-stroke depression
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new medicine called zuranolone (allopregnanolone) for people with depression after a stroke. It aims to see if the drug can help improve mood when taken over a short period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You had a stroke (from a clot or bleeding) within the last year.
- You have been feeling depressed for at least 2 weeks and a doctor says it's moderate to severe.
- You do not have serious liver or kidney problems.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You have not had a history of bipolar disorder, schizophrenia, or depression that didn't get better with treatment before the stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if breathing pure oxygen in a special chamber (hyperbaric oxygen therapy) can help people who have been depressed since having a stroke. It may offer a new way to treat depression that hasn't improved with standard medications.
This study tests a new treatment called allopregnanolone for veterans who have both a past mild traumatic brain injury and current depression, along with chronic pain. The goal is to see if this treatment can improve mood and reduce pain.
This study checks how people with postpartum depression feel over time after starting zuranolone. It uses simple questionnaires to track changes in symptoms.
This trial studies a natural brain chemical called allopregnanolone in women with premenstrual dysphoric disorder (PMDD) that responds to SSRI antidepressants. It aims to understand how the brain adapts and whether this treatment could help.
This trial tests whether allopurinol, a medication typically used for gout, might help reduce depression symptoms when added to standard depression treatment. Researchers believe it may work by reducing inflammation in the brain that contributes to depression.
This study tests a new oral medication called Zelquistinel (taken as a tablet) against a placebo for treating major depressive disorder. Researchers want to see if it can reduce depression symptoms, especially when other antidepressants haven't been tried or haven't worked.
Hear when a new Post-stroke Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.